Thomas J. Herzfeld Advisors, Inc. Eli Lilly & CO Transaction History

Thomas J. Herzfeld Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $287,336 - $396,137	661 New	661 $355 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $350 - $468	-1 Reduced 0.15%	662 $310,000
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $5,853 - $6,872	21 Added 3.27%	663 $215,000
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $5,729 - $6,895	42 Added 7.0%	642 $96,000
Q2 2017 Aug 14, 2017	BUY	N/A	600	600 $49,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.